Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro
1997

Vitamin D and Pancreatic Cancer

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): KW Colston, SY James, EA Ofori-Kuragul, L Binderup, AG Grant

Primary Institution: St George's Hospital Medical School

Hypothesis

Can the vitamin D analogue EB 1089 inhibit the growth of pancreatic carcinoma cells both in vitro and in vivo?

Conclusion

The vitamin D analogue EB 1089 significantly inhibits the growth of pancreatic carcinoma cells without causing hypercalcaemia.

Supporting Evidence

  • EB 1089 inhibited the growth of pancreatic carcinoma cells in vitro.
  • EB 1089 was administered to mice and significantly inhibited tumor growth.
  • Treatment did not result in hypercalcaemia in the treated animals.

Takeaway

This study found that a special form of vitamin D can help stop the growth of pancreatic cancer cells in lab tests and in mice.

Methodology

The study used human pancreatic carcinoma cell lines and xenografts in immunodeficient mice to assess the effects of EB 1089.

Limitations

The study is preliminary and the mechanisms of action of EB 1089 are not fully understood.

Participant Demographics

Female nude mice, 6-8 weeks of age.

Statistical Information

P-Value

0.007

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication